CVS Health Co. (NYSE:CVS) Position Trimmed by Van Cleef Asset Management Inc

Van Cleef Asset Management Inc lowered its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 45.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,504 shares of the pharmacy operator's stock after selling 7,973 shares during the period. Van Cleef Asset Management Inc's holdings in CVS Health were worth $427,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. Hotchkis & Wiley Capital Management LLC lifted its stake in shares of CVS Health by 34.8% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock worth $748,085,000 after purchasing an additional 3,071,613 shares during the period. ARGA Investment Management LP increased its stake in CVS Health by 7,567.7% in the fourth quarter. ARGA Investment Management LP now owns 2,402,901 shares of the pharmacy operator's stock valued at $107,866,000 after purchasing an additional 2,371,563 shares during the last quarter. State Street Corp lifted its position in CVS Health by 3.6% during the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock worth $3,554,475,000 after buying an additional 1,989,066 shares during the period. TOMS Capital Investment Management LP acquired a new stake in CVS Health in the 3rd quarter worth about $121,987,000. Finally, Mizuho Markets Americas LLC grew its holdings in CVS Health by 1,470.2% in the third quarter. Mizuho Markets Americas LLC now owns 1,396,464 shares of the pharmacy operator's stock valued at $87,810,000 after purchasing an additional 1,307,531 shares during the period. Hedge funds and other institutional investors own 80.66% of the company's stock.

Insider Activity at CVS Health

In related news, Director Michael F. Mahoney acquired 30,000 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the purchase, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.24% of the stock is currently owned by insiders.

Analysts Set New Price Targets

CVS has been the topic of a number of research analyst reports. Royal Bank of Canada decreased their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. Leerink Partners upgraded CVS Health from a "market perform" rating to an "outperform" rating and raised their price objective for the stock from $55.00 to $75.00 in a report on Thursday, February 13th. Barclays boosted their price objective on shares of CVS Health from $71.00 to $73.00 and gave the stock an "overweight" rating in a research note on Thursday, February 13th. Piper Sandler reduced their target price on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a report on Monday, November 25th. Finally, Cantor Fitzgerald upgraded CVS Health from a "neutral" rating to an "overweight" rating in a report on Wednesday, February 12th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and an average target price of $69.83.

CVS Health Stock Performance

CVS traded down $0.90 on Monday, hitting $64.82. 7,067,486 shares of the company's stock were exchanged, compared to its average volume of 12,413,437. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The stock has a fifty day moving average of $54.33 and a two-hundred day moving average of $56.47. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The firm has a market cap of $81.72 billion, a PE ratio of 17.71, a P/E/G ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, research analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.10%. CVS Health's dividend payout ratio (DPR) is presently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.